Sønderhøj, Denmark—Arla Foods Ingredients has obtained GRAS approval for its use of alpha-lactalbumin in infant formula, according to a press release.
FDA issued a ‘no objection letter’ with regards to the safety of fractionated whey protein concentrate containing 41% alpha-lactalbumin, marketed by Arla as Lacprodan ALPHA-10, when used in infant formula.
Alpha-lactalbumin is the most abundant protein in human milk, comprising about 25% of total protein content. Lacprodan can therefore be used to make an infant formula that more clowely emulates human milk. Alpha-lactalbumin has also been associated with a reduction is gastrointestinal events, a healthy gut microbiota, and protection against intestinal infections.
Related: Baby Love
Arla Food Ingredients Reveals Details of Quality Process Behind Whey Products
Arla Foods Ingredients Releases Optimized Comfort Concept for Infant Formula
Kal Ramanujam, senior scientific advisor of pediatrics at Arla, said in the release: “Lacprodan ALPHA-10 delivers safe and documented benefits when used in infant formula. This approval is a regulatory milestone in the US. It will benefit millions of babies by allowing them to consumer clinically documented levels of bovine alpha-lactalbumin.”
The GRAS notice is available here.